Intrathecal baclofen for generalized dystonia
- PMID: 11665821
- DOI: 10.1017/s0012162201001190
Intrathecal baclofen for generalized dystonia
Abstract
The aim of this study was to evaluate the effects of intrathecal bacolfen (ITB) on patients with severe generalized dystonia. Eighty-six participants ranging in age from 3 to 42 years (median age 13 years) with generalized dystonia refractory to oral medications were offered treatment with ITB. Dystonia was associated with cerebral palsy in 71% of participants. Response to ITB was tested by continuous infusions in 72%, and by bolus injections in 17% of participants who had both dystonia and spasticity. Ninety-one percent of participants responded to the screening infusion and 93% to the bolus injections. Pumps were implanted in 77 participants. Dystonia scores at 3, 6, 12, and 24 months were significantly decreased (p<0.005) compared with baseline scores. Dystonia scores were significantly lower in those with intrathecal catheters positioned at T4, or higher than in those with catheters at T6 or lower (p=0.005). Ninety-two percent of participants implanted with a pump retained their responses to ITB during a median follow-up of 29 months. Patient questionnaires indicated that quality of life and ease of care improved in 86% and speech improved in 33%. Side effects of ITB occurred in 26% of participants. Surgical complications occurred in 38% and included CSF leaks, infections, and catheter problems. ITB is probably the treatment of choice for generalized dystonia if oral medications are ineffective.
Similar articles
-
Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience.J Neurosurg Pediatr. 2014 Mar;13(3):301-6. doi: 10.3171/2013.11.PEDS13253. Epub 2014 Jan 3. J Neurosurg Pediatr. 2014. PMID: 24404968
-
Positive experience with intrathecal baclofen treatment in children with severe cerebral palsy.Dan Med J. 2015 Jan;62(1):A4999. Dan Med J. 2015. PMID: 25557334
-
Continuous intrathecal baclofen infusion for symptomatic generalized dystonia.Neurosurgery. 1996 May;38(5):934-8; discussion 938-9. doi: 10.1097/00006123-199605000-00015. Neurosurgery. 1996. PMID: 8727818
-
Intrathecal baclofen therapy in children.Neurosurg Focus. 2006 Aug 15;21(2):e3. doi: 10.3171/foc.2006.21.2.4. Neurosurg Focus. 2006. PMID: 16918224 Review.
-
Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.Dev Med Child Neurol. 2011 Oct;53(10):885-95. doi: 10.1111/j.1469-8749.2011.03992.x. Epub 2011 Jun 3. Dev Med Child Neurol. 2011. PMID: 21635230 Review.
Cited by
-
Treatment of dystonia with deep brain stimulation.Neurotherapeutics. 2008 Apr;5(2):320-30. doi: 10.1016/j.nurt.2008.01.002. Neurotherapeutics. 2008. PMID: 18394573 Free PMC article. Review.
-
A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders.Front Psychiatry. 2021 Jun 2;12:678088. doi: 10.3389/fpsyt.2021.678088. eCollection 2021. Front Psychiatry. 2021. PMID: 34149483 Free PMC article.
-
Utilizing combination intrathecal baclofen and analgesic medication to manage spasticity and pain in patients with pediatric-onset disability: Case series.J Pediatr Rehabil Med. 2024;17(1):57-66. doi: 10.3233/PRM-220100. J Pediatr Rehabil Med. 2024. PMID: 38552121 Free PMC article.
-
Efficacy of Selective Dorsal Rhizotomy and Intrathecal Baclofen Pump in the Management of Spasticity.Adv Tech Stand Neurosurg. 2022;45:379-403. doi: 10.1007/978-3-030-99166-1_13. Adv Tech Stand Neurosurg. 2022. PMID: 35976458
-
Surgical management of spasticity.J Child Orthop. 2013 Nov;7(5):389-94. doi: 10.1007/s11832-013-0512-9. Epub 2013 Oct 6. J Child Orthop. 2013. PMID: 24432100 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical